1. Home
  2. GHRS vs TK Comparison

GHRS vs TK Comparison

Compare GHRS & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • TK
  • Stock Information
  • Founded
  • GHRS 2018
  • TK 1973
  • Country
  • GHRS Ireland
  • TK Bermuda
  • Employees
  • GHRS N/A
  • TK N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • TK Marine Transportation
  • Sector
  • GHRS Health Care
  • TK Consumer Discretionary
  • Exchange
  • GHRS Nasdaq
  • TK Nasdaq
  • Market Cap
  • GHRS 753.0M
  • TK 643.8M
  • IPO Year
  • GHRS 2021
  • TK 1995
  • Fundamental
  • Price
  • GHRS $13.08
  • TK $8.09
  • Analyst Decision
  • GHRS Strong Buy
  • TK
  • Analyst Count
  • GHRS 8
  • TK 0
  • Target Price
  • GHRS $30.63
  • TK N/A
  • AVG Volume (30 Days)
  • GHRS 254.5K
  • TK 681.6K
  • Earning Date
  • GHRS 08-07-2025
  • TK 07-30-2025
  • Dividend Yield
  • GHRS N/A
  • TK 24.81%
  • EPS Growth
  • GHRS N/A
  • TK N/A
  • EPS
  • GHRS N/A
  • TK 0.88
  • Revenue
  • GHRS N/A
  • TK $992,518,000.00
  • Revenue This Year
  • GHRS N/A
  • TK N/A
  • Revenue Next Year
  • GHRS N/A
  • TK N/A
  • P/E Ratio
  • GHRS N/A
  • TK $9.09
  • Revenue Growth
  • GHRS N/A
  • TK N/A
  • 52 Week Low
  • GHRS $6.00
  • TK $5.65
  • 52 Week High
  • GHRS $20.50
  • TK $9.78
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 47.54
  • TK 60.79
  • Support Level
  • GHRS $11.32
  • TK $7.34
  • Resistance Level
  • GHRS $13.15
  • TK $7.62
  • Average True Range (ATR)
  • GHRS 0.73
  • TK 0.22
  • MACD
  • GHRS 0.05
  • TK 0.08
  • Stochastic Oscillator
  • GHRS 77.19
  • TK 87.72

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: